CEBP CTRC-AACR San Antonio Breast Cancer Symposium Cancer Health Disparities Conference 2009
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shields, P. G.
Right arrow Articles by Caporaso, N. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shields, P. G.
Right arrow Articles by Caporaso, N. E.

Cancer Epidemiology Biomarkers & Prevention, Vol 7, Issue 6 453-458, Copyright © 1998 by American Association for Cancer Research


ARTICLES

Dopamine D4 receptors and the risk of cigarette smoking in African-Americans and Caucasians

PG Shields, C Lerman, J Audrain, ED Bowman, D Main, NR Boyd and NE Caporaso
Molecular Epidemiology Section, Laboratory of Human Carcinogenesis, Division of Basic Sciences, National Cancer Institute, Bethesda, Maryland 20892, USA. Peter_G_Shields@nih.gov

An understanding of why people smoke cigarettes can have an important impact on smoking prevention and cessation. People smoke cigarettes to maintain nicotine levels in the body, and nicotine has been implicated in the stimulation of brain reward mechanisms via central neuronal dopaminergic pathways. In this study, we evaluated the association of smoking and smoking cessation with a dopamine D4 receptor 48-bp variable nucleotide tandem repeat polymorphism in which the seven-repeat allele (D4.7) reduces dopamine affinity. Smokers (n = 283) and nonsmokers (n = 192) were recruited through local media for a case-control study of smoking. After giving informed consent and answering a behavioral questionnaire, smokers underwent a single minimal-contact session of smoking cessation counseling and then were followed for up to 1 year. The frequency of the dopamine D4 receptor genetic polymorphism using PCR was determined, and individuals were classified by the number of repeat alleles (two to five repeats as S and six to eight repeats as L). Persons with those genotypes including only S alleles (homozygote S/S) were compared with those with at least one L allele (heterozygote S/L and homozygote L/L). Chi2 tests of association, Fisher's exact test, and Student's t test were used. Ps were two-tailed. The data show that African-Americans (n = 72) who had at least one L allele had a higher risk of smoking (odds ratio, 7.7; 95% confidence interval, 1.5-39.9; P = 0.006), shorter time to the first cigarette in the morning (P = 0.03), and earlier age at smoking initiation (P = 0.09) compared with homozygote S/S genotypes. After smoking cessation counseling, none of the African-American smokers with an L allele were abstinent at 2 months, compared with 35% of the smokers who were homozygote S/S (P = 0.02). The analysis of Caucasians (n = 403) did not suggest a similar smoking risk for the D4 genotypes (odds ratio, 1.0; 95% confidence interval, 0.6-1.6; P = 0.90), or smoking cessation (P = 0.75). Although the number of African-Americans is small, this study is consistent with the hypothesis that the L alleles increase the risk of smoking because these individuals are prone to use nicotine to stimulate synaptic dopamine transmission. If replicated, the data indicate that a single minimal-contact session of cessation counseling, similar to what is typically provided in primary care physician offices, is ineffective in African-American smokers who have at least one L allele. The finding of an effect for these polymorphic loci in African-Americans, but not Caucasians, suggests that the variable nucleotide tandem repeat studied here is a marker for another polymorphic site in African-Americans, but not in Caucasians.


This article has been cited by other articles:


Home page
Hum Mol GenetHome page
S. F. Saccone, A. L. Hinrichs, N. L. Saccone, G. A. Chase, K. Konvicka, P. A.F. Madden, N. Breslau, E. O. Johnson, D. Hatsukami, O. Pomerleau, et al.
Cholinergic nicotinic receptor genes implicated in a nicotine dependence association study targeting 348 candidate genes with 3713 SNPs
Hum. Mol. Genet., January 1, 2007; 16(1): 36 - 49.
[Abstract] [Full Text] [PDF]


Home page
Arch Gen PsychiatryHome page
A. L. Brody, M. A. Mandelkern, R. E. Olmstead, D. Scheibal, E. Hahn, S. Shiraga, E. Zamora-Paja, J. Farahi, S. Saxena, E. D. London, et al.
Gene Variants of Brain Dopamine Pathways and Smoking-Induced Dopamine Release in the Ventral Caudate/Nucleus Accumbens.
Arch Gen Psychiatry, July 1, 2006; 63(7): 808 - 816.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
C. H. Halbert, O. H. Gandy Jr., A. Collier, and L. Shaker
Intentions to Participate in Genetics Research among African American Smokers
Cancer Epidemiol. Biomarkers Prev., January 1, 2006; 15(1): 150 - 153.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. L. Sabichi, M.-F. Demierre, E. T. Hawk, C. E. Lerman, and S. M. Lippman
Frontiers in Cancer Prevention Research
Cancer Res., September 15, 2003; 63(18): 5649 - 5655.
[Full Text] [PDF]


Home page
ChestHome page
V. Batra, A. A. Patkar, W. H. Berrettini, S. P. Weinstein, and F. T. Leone
The Genetic Determinants of Smoking
Chest, May 1, 2003; 123(5): 1730 - 1739.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
P. G. Shields
Tobacco Smoking, Harm Reduction, and Biomarkers
J Natl Cancer Inst, October 2, 2002; 94(19): 1435 - 1444.
[Abstract] [Full Text] [PDF]


Home page
Tobacco ControlHome page
A Hyland, S Garten, G A Giovino, and K M Cummings
Mentholated cigarettes and smoking cessation: findings from COMMIT
Tob. Control, June 1, 2002; 11(2): 135 - 139.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
K. Yoshida, N. Hamajima, K.-i. Kozaki, H. Saito, K. Maeno, T. Sugiura, K. Ookuma, and T. Takahashi
Association between the Dopamine D2 Receptor A2/A2 Genotype and Smoking Behavior in the Japanese
Cancer Epidemiol. Biomarkers Prev., April 1, 2001; 10(4): 403 - 405.
[Abstract] [Full Text]


Home page
JCOHome page
P. G. Shields and C. C. Harris
Cancer Risk and Low-Penetrance Susceptibility Genes in Gene-Environment Interactions
J. Clin. Oncol., June 11, 2000; 18(11): 2309 - 2315.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
S. C. Dulawa, D. K. Grandy, M. J. Low, M. P. Paulus, and M. A. Geyer
Dopamine D4 Receptor-Knock-Out Mice Exhibit Reduced Exploration of Novel Stimuli
J. Neurosci., November 1, 1999; 19(21): 9550 - 9556.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
H. Ishikawa, T. Ohtsuki, H. Ishiguro, K. Yamakawa-Kobayashi, K. Endo, Y.-L. Lin, H. Yanagi, S. Tsuchiya, K.-i. Kawata, H. Hamaguchi, et al.
Association between Serotonin Transporter Gene Polymorphism and Smoking among Japanese Males
Cancer Epidemiol. Biomarkers Prev., September 1, 1999; 8(9): 831 - 833.
[Abstract] [Full Text]


Home page
JNCI J Natl Cancer InstHome page
A. W. Bergen and N. Caporaso
Cigarette Smoking
J Natl Cancer Inst, August 18, 1999; 91(16): 1365 - 1375.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1998 by the American Association for Cancer Research.